FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PN2SYK2

Market Closed - Deutsche Boerse AG 15:50:31 2024-05-31 EDT
65.74 EUR -1.14% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-1.78%
1 month-1.78%
Date Price Change
24-05-31 65.74 -1.14%
24-05-30 66.5 -0.91%
24-05-29 67.11 +2.29%
24-05-28 65.61 +1.80%
24-05-27 64.45 -0.43%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:50 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN2SYK
ISINDE000PN2SYK2
Date issued 2022-01-21
Strike 340.5 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 75.79
Lowest since issue 28.2
Spread 1.34
Spread %1.97%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus